klow peptide uses 80mg KLOW BLEND Peptide (80mg) |

Historical research on GHK-Cu's biological functions The review consolidates findings from laboratory studies, animal models, and human clinical trials spanning from the 1980s to 2018

(2015), BioMed Research International 2015:648108, PubMed 26236730 Statistics from research literature Discovered by Loren Pickart in human blood plasma in 1973 , as a factor extending the longevity of cultured liver cells The smallest peptide with documented pharmacological activity: 3 amino acids (Gly-His-Lys) + one Cu ion Molecular weight: 402 Da EU cosmetic INCI name: Copper Tripeptide-1 (registered in EU Commission CosIng database) Gene expression modulation: 4 000 human genes (Connectivity Map dataset, Pickart 2015) Plasma level in healthy humans declines from ~200 ng/mL at age 20 to ~80 ng/mL at age 60 (62 % decrease) Most-studied bioactivities: fibroblast proliferation , type I/III collagen synthesis , antioxidant activity (SOD upregulation) Reference sources (PubMed) Pickart L., Vasquez-Soltero JM., Margolina A

(84) utilized advanced ultraviolet-visible spectroscopy (UV-VIS) and quantum chemical calculations to investigate curcumins tautomerism in ethanol/water binary solutions (84)

It also summarizes recent advances in therapeutic strategies targeting mitochondria, including pharmacological, genetic, cellular, and material-based approaches, to offer new perspectives and directions for future treatments

Williams EM, Little RF, Mowday AM, Rich MH, Chan-Hyams JVE, Copp JN, et al

Healthcare Professionals